Research map: Population pharmacokinetics of total and free mycophenolic acid in plasma in paediatric patients with nephrotic syndrome including salivary concentrations and the pharmacodynamics

Back to the article

Papers in this map

  1. New Equations to Estimate GFR in Children with CKD · George J. Schwartz · 2009 · 3830 citations · Cited by this paper
  2. Diurnal variation of cisplatin-induced anti-tumor effect and renal toxicity in mice bearing human colon cancer cells · 2026 · Related
  3. Mechanism-Based Concepts of Size and Maturity in Pharmacokinetics · Brian Joseph Anderson · 2007 · 1126 citations · Cited by this paper
  4. Targeting mitochondrial deubiquitinase USP30 to induce mitophagy in heteroplasmic mitochondrial diseases · 2026 · Related
  5. Ways to Fit a PK Model with Some Data Below the Quantification Limit · Stuart L. Beal · 2001 · 1123 citations · Cited by this paper
  6. Potential antidepressant properties of aminophylline in male mice exposed to chronic restraint stress · 2026 · Related
  7. Mycophenolic acid binding to human serum albumin: characterization and relation to pharmacodynamics · Irena A. Nowak · 1995 · 315 citations · Cited by this paper
  8. Hypocholesterolemic agents and the gut microbiota: a review of interactions and modulatory activity · 2026 · Related
  9. IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome · Agnes Trautmann · 2022 · 296 citations · Cited by this paper
  10. The effect of salidroside, an active component of Rhodiola rosea, on the metabolic activity of rat and human cytochromes P450 in preclinical studies · 2026 · Related
  11. The Pharmacokinetic-Pharmacodynamic Relationship for Total and Free Mycophenolic Acid in Pediatric Renal Transplant Recipients · Lutz Thorsten Weber · 2002 · 283 citations · Cited by this paper
  12. Cannabidiol (CBD) modulates the serotonin–kynurenine metabolic balance in the brain of morphine-tolerant neuropathic rats · 2026 · Related
  13. Population Pharmacokinetics I: Background, Concepts, and Models · Ene Ette · 2004 · 248 citations · Cited by this paper
  14. Targeting epigenetic and DNA topology mechanisms: histone deacetylases and topoisomerase inhibitors in combination and dual inhibition approaches · 2026 · Related
  15. Pharmacokinetics of mycophenolic acid (MPA) and determinants of MPA free fraction in pediatric and adult renal transplant recipients. German Study group on Mycophenolate Mofetil Therapy in Pediatric Renal Transplant Recipients. · Lutz Thorsten Weber · 1998 · 220 citations · Cited by this paper
  16. Topical latanoprost acid for female androgenetic alopecia: a pilot proof-of-concept trial with mechanistic evidence of prostaglandin F2α receptor activation · 2026 · Related
  17. Personalized Therapy for Mycophenolate: Consensus Report by the International Association of Therapeutic Drug Monitoring and Clinical Toxicology · Stein Bergan · 2021 · 206 citations · Cited by this paper
  18. Kisspeptin-10 regulates glycosaminoglycan and decorin content in human cardiac fibroblast cultures · 2026 · Related
  19. Tips and traps analyzing pediatric PK data · Brian Joseph Anderson · 2011 · 165 citations · Cited by this paper
  20. Italian regional data and oropharyngeal adverse events to drugs and vaccines: insights from a 3-year spontaneous reporting (2022–2024) · 2026 · Related
  21. Free drug fraction vs. free drug concentration: a matter of frequent confusion · Pierre‐Louis Toutain · 2002 · 129 citations · Cited by this paper
  22. Pharmacokinetic role of protein binding of mycophenolic acid and its glucuronide metabolite in renal transplant recipients · Brenda C. M. de Winter · 2009 · 88 citations · Cited by this paper
  23. Interpatient variability in IMPDH activity in MMF-treated renal transplant patients is correlated with IMPDH type II 3757T>C polymorphism · Ferdi Sombogaard · 2009 · 83 citations · Cited by this paper
  24. A descriptive systematic review of salivary therapeutic drug monitoring in neonates and infants · Laura A. Hutchinson · 2018 · 70 citations · Cited by this paper
  25. Allometry Is a Reasonable Choice in Pediatric Drug Development · Tao Liu · 2016 · 68 citations · Cited by this paper
  26. Population Pharmacokinetics of Mycophenolic Acid in Kidney Transplant Pediatric and Adolescent Patients · Salomé Payen · 2005 · 63 citations · Cited by this paper
  27. Pharmacodynamic monitoring of immunosuppressive drugs · Randall W. Yatscoff · 1998 · 57 citations · Cited by this paper
  28. Development of a Bayesian estimator for the therapeutic drug monitoring of mycophenolate mofetil in children with idiopathic nephrotic syndrome · Franck Saint‐Marcoux · 2011 · 55 citations · Cited by this paper
  29. Improved Assay for the Nonradioactive Determination of Inosine 5'-Monophosphate Dehydrogenase Activity in Peripheral Blood Mononuclear Cells · Petra Glander · 2009 · 55 citations · Cited by this paper
  30. Population pharmacokinetics of mycophenolic acid in pediatric renal transplant patients using parametric and nonparametric approaches · Aurélie Prémaud · 2010 · 46 citations · Cited by this paper
  31. The pharmacokinetics and pharmacodynamics of mycophenolate mofetil in younger and elderly renal transplant recipients · Jiangtao Tang · 2016 · 46 citations · Cited by this paper
  32. Monitoring of Inosine Monophosphate Dehydrogenase Activity as a Biomarker for Mycophenolic Acid Effect: Potential Clinical Implications · Nicole A. Weimert · 2007 · 42 citations · Cited by this paper
  33. Pharmacokinetic Modelling of the Plasma Protein Binding of Mycophenolic Acid in Renal Transplant Recipients · Reinier M. van Hest · 2009 · 42 citations · Cited by this paper
  34. Population pharmacokinetics and Bayesian estimator of mycophenolic acid in children with idiopathic nephrotic syndrome · Wei Zhao · 2010 · 39 citations · Cited by this paper
  35. Pediatric idiopathic steroid-sensitive nephrotic syndrome: diagnosis and therapy —short version of the updated German best practice guideline (S2e) — AWMF register no. 166-001, 6/2020 · Rasmus Ehren · 2021 · 35 citations · Cited by this paper
  36. Population pharmacokinetics of unbound mycophenolic acid in adult allogeneic haematopoietic cell transplantation: effect of pharmacogenetic factors · Adam R. Frymoyer · 2012 · 32 citations · Cited by this paper
  37. Customized Mycophenolate Dosing Based on Measuring Inosine-Monophosphate Dehydrogenase Activity Significantly Improves Patients' Outcomes After Renal Transplantation · Matthias C. Raggi · 2010 · 32 citations · Cited by this paper
  38. Prediction of Free from Total Mycophenolic Acid Concentrations in Stable Renal Transplant Patients: A Population-Based Approach · Helena Colom · 2017 · 31 citations · Cited by this paper
  39. Monitoring of mycophenolate mofetil metabolites in children with nephrotic syndrome and the proposed novel target values of pharmacokinetic parameters · Joanna Sobiak · 2015 · 31 citations · Cited by this paper

Source: OpenAlex (CC0)